510 related articles for article (PubMed ID: 20590485)
1. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
Epstein BJ
Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
[TBL] [Abstract][Full Text] [Related]
2. Use of single-pill combination therapy in the evolving paradigm of hypertension management.
Calhoun DA
Expert Opin Pharmacother; 2009 Aug; 10(12):1869-74. PubMed ID: 19496740
[TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
4. Issues in blood pressure control and the potential role of single-pill combination therapies.
Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
[TBL] [Abstract][Full Text] [Related]
5. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
6. Optimizing hypertension management in clinical practice.
Heagerty A
J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
[TBL] [Abstract][Full Text] [Related]
7. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy.
Basile J; Neutel J
Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):119-27. PubMed ID: 20042448
[TBL] [Abstract][Full Text] [Related]
8. A role for single-pill triple therapy in hypertension.
Elijovich F; Laffer C
Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):231-40. PubMed ID: 19443512
[TBL] [Abstract][Full Text] [Related]
9. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
Weir MR; Zappe D; Orloski LA; Sowers JR
J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
[TBL] [Abstract][Full Text] [Related]
10. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
Roberts ME; Epstein BJ
J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy in the treatment of hypertension.
Escobar C; Barrios V
Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
[TBL] [Abstract][Full Text] [Related]
12. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
13. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
White WB
Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
[TBL] [Abstract][Full Text] [Related]
14. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
Neutel JM
Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
Van der Niepen P; Woestenburg A; Brié H; Vancayzeele S; MacDonald K; Denhaerynck K; Lee C; Hermans C; Abraham I
Ann Pharmacother; 2009 May; 43(5):849-61. PubMed ID: 19351876
[TBL] [Abstract][Full Text] [Related]
17. Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Gupte J; Staikos L; Hua TA; Shi V; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
Blood Press; 2008; 17(1):7-17. PubMed ID: 18568687
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
19. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
Frampton JE; Scott LJ
Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
[TBL] [Abstract][Full Text] [Related]
20. Adding a low-dose antihypertensive regimen would substantially improve the control of hypertension and reduce cardiovascular morbidity among uncomplicated hypertensive patients.
Ahola TL; Kantola IM; Mäki J; Reunanen A; Jula AM
Eur J Prev Cardiol; 2012 Aug; 19(4):712-22. PubMed ID: 21609976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
